Counterpoint Mutual Funds LLC Acquires New Shares in Alignment Healthcare, Inc. $ALHC

Counterpoint Mutual Funds LLC bought a new stake in shares of Alignment Healthcare, Inc. (NASDAQ:ALHC) during the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor bought 28,630 shares of the company’s stock, valued at approximately $500,000.

Other institutional investors have also recently made changes to their positions in the company. Teacher Retirement System of Texas boosted its holdings in Alignment Healthcare by 85.8% in the third quarter. Teacher Retirement System of Texas now owns 102,827 shares of the company’s stock worth $1,794,000 after purchasing an additional 47,472 shares during the last quarter. Y Intercept Hong Kong Ltd purchased a new stake in Alignment Healthcare during the 3rd quarter valued at $3,499,000. Inspire Investing LLC bought a new position in shares of Alignment Healthcare during the 3rd quarter valued at $1,129,000. Ameritas Investment Partners Inc. boosted its stake in shares of Alignment Healthcare by 32.9% in the 2nd quarter. Ameritas Investment Partners Inc. now owns 13,031 shares of the company’s stock worth $182,000 after buying an additional 3,225 shares during the last quarter. Finally, Jump Financial LLC grew its holdings in shares of Alignment Healthcare by 173.8% in the second quarter. Jump Financial LLC now owns 1,056,600 shares of the company’s stock worth $14,792,000 after acquiring an additional 670,750 shares during the period. Hedge funds and other institutional investors own 86.19% of the company’s stock.

Analysts Set New Price Targets

A number of research firms have weighed in on ALHC. Weiss Ratings reissued a “sell (d-)” rating on shares of Alignment Healthcare in a report on Wednesday, January 21st. TD Cowen upped their price target on shares of Alignment Healthcare from $18.50 to $25.00 and gave the company a “buy” rating in a research report on Friday, January 16th. UBS Group increased their price objective on shares of Alignment Healthcare from $18.00 to $21.00 and gave the stock a “neutral” rating in a research note on Wednesday, January 14th. KeyCorp restated an “overweight” rating and set a $28.00 target price on shares of Alignment Healthcare in a research report on Thursday, January 22nd. Finally, JPMorgan Chase & Co. upped their target price on shares of Alignment Healthcare from $23.00 to $26.00 and gave the company an “overweight” rating in a report on Thursday, February 5th. One investment analyst has rated the stock with a Strong Buy rating, nine have issued a Buy rating, three have issued a Hold rating and one has given a Sell rating to the stock. According to data from MarketBeat.com, the stock has an average rating of “Moderate Buy” and a consensus price target of $23.95.

Insider Buying and Selling at Alignment Healthcare

In related news, insider Andreas P. Wagner sold 22,238 shares of the business’s stock in a transaction that occurred on Tuesday, February 10th. The stock was sold at an average price of $20.47, for a total value of $455,211.86. Following the transaction, the insider directly owned 169,805 shares of the company’s stock, valued at approximately $3,475,908.35. The trade was a 11.58% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, CEO John E. Kao sold 180,000 shares of the company’s stock in a transaction that occurred on Tuesday, February 10th. The stock was sold at an average price of $20.49, for a total value of $3,688,200.00. Following the completion of the transaction, the chief executive officer owned 2,652,641 shares of the company’s stock, valued at $54,352,614.09. The trade was a 6.35% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Over the last quarter, insiders sold 2,125,938 shares of company stock valued at $41,799,570. 6.60% of the stock is currently owned by corporate insiders.

Alignment Healthcare Price Performance

Shares of NASDAQ:ALHC opened at $19.60 on Wednesday. The company has a market capitalization of $3.92 billion, a P/E ratio of -163.33, a P/E/G ratio of 5.07 and a beta of 1.16. Alignment Healthcare, Inc. has a 1-year low of $11.63 and a 1-year high of $23.87. The firm’s 50 day simple moving average is $21.02 and its two-hundred day simple moving average is $18.46. The company has a debt-to-equity ratio of 1.99, a current ratio of 1.61 and a quick ratio of 1.61.

About Alignment Healthcare

Alignment Healthcare, Inc (NASDAQ: ALHC) is a health care company specializing in value-based care for Medicare Advantage beneficiaries. The company leverages an integrated care model that combines in-home clinical services, telehealth capabilities and digital health tools to manage chronic conditions, improve outcomes and enhance patient experience.

At the core of Alignment Healthcare’s approach is a proprietary technology platform that aggregates real-time clinical and claims data to support preventive care, risk stratification and personalized care plans.